Stocks and Investing
Stocks and Investing
Tue, October 17, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, October 16, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Ransom Upgraded (ALHC) to Strong Buy and Increased Target to $10 on, Oct 16th, 2023
John Ransom of Raymond James, Upgraded "Alignment Healthcare, Inc." (ALHC) to Strong Buy and Increased Target from $9 to $10 on, Oct 16th, 2023.
John has made no other calls on ALHC in the last 4 months.
There are 4 other peers that have a rating on ALHC. Out of the 4 peers that are also analyzing ALHC, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $9 on, Thursday, October 12th, 2023
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $6 on, Thursday, July 13th, 2023
- Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $10 on, Friday, July 7th, 2023
This is the rating of the analyst that currently disagrees with John
- Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Decreased Target to $12 on, Wednesday, August 30th, 2023
Contributing Sources